SWOG clinical trial number
SWOG-8900
A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma
Closed
Phase
Accrual
100%
Published
Abbreviated Title
A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma
Activated
05/01/1989
Closed
12/01/1991
Publication Information Expand/Collapse
1994
A phaseIII randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma: A Southwest Oncology Group study